1. Early effectiveness of COVID-19 vaccination with BNT162b2 mRNA vaccine and ChAdOx1 adenovirus vector vaccine on symptomatic disease, hospitalisations and mortality in older adults in England;Bernal
2. Effectiveness of Pfizer-BioNTech and Moderna vaccines Against COVID-19 among hospitalized adults aged ≥65 years - United States, January-March 2021;Tenforde;MMWR Morb Mortal Wkly Rep.,2021
3. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination;Greinacher;N Engl J Med.
4. Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination;Schultz;N Engl J Med.
5. Johnson & Johnson/Janssen COVID-19 vaccine and thrombosis with thrombocytopenia syndrome (TTS): update for clinicians.;Centers for Disease Control and Prevention Emergency Preparedness and Response